Close Menu

CPTAC

The project aims to develop multiple-reaction monitoring mass spec and immuno-MRM mass spec assays for roughly 100 proteins involved in RAS signaling.

From research collaborations to corporate acquisitions, attention from the broader scientific community highlighted the field's capabilities and limitations.

NEW YORK (GenomeWeb) – An international research team has completed a multi-omic pan-cancer analysis of data on 3,527 tumors spanning 12 different cancer types generated by the National Cancer Institute's Cancer Genome Atlas consortium.

CPTAC Launches MRM Assay Portal

Premium

NEW YORK (GenomeWeb) – The National Cancer Institute's Clinical Proteomic Tumor Analysis Consortium has launched an assay portal for multiple-reaction monitoring mass spec assays.

NEW YORK (GenomeWeb) – Researchers from the National Cancer Institute's Clinical Proteomic Tumor Analysis Consortium have completed a proteogenomics analysis of human colon and rectal cancer tumors.

NEW YORK (GenomeWeb News) – The National Cancer Institute's Clinical Proteomic Tumor Analysis Consortium this week released a comprehensive dataset of proteomic analyses of 174 high grade serous ovarian tumor samples previously analyzed by The Cancer Genome Atlas initiative.

Researchers at Utrecht University have completed a proteogenomics study of rat liver tissue, integrating whole genome sequencing, RNA-seq, and mass spec-based proteomics.

The National Cancer Institute's Clinical Proteomic Tumor Analysis Consortium has publicly released its first proteomic data set.

Broad Institute researchers have devised a method for serial enrichment and analysis of protein post-translational modifications.

In March 2010, Austin, Texas-based diagnostics firm Vermillion launched sales of its OVA1 ovarian cancer test.

Pages

The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.

The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.

News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.

In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.